Lung Nodule Detection and Characterization Automation Workflow

This workflow automates the most repetitive bottleneck in lung cancer screening: the initial detection and risk stratification of pulmonary nodules from high-volume CT scans. By orchestrating specialized AI models for detection, false-positive reduction, and feature analysis (size, density, shape), it eliminates manual slice-by-slice review for normal cases. The operational upside comes from redirecting 60-70% of radiologist effort to only the complex, high-risk findings, directly increasing screening program capacity and reducing time-to-diagnosis without compromising safety. Implementation requires integration with PACS for DICOM ingestion and a rules engine to apply clinical classification frameworks like Lung-RADS.

Architecturally, the workflow is built on an orchestrator like LangGraph, which sequences agents, manages state, and handles exceptions. Critical controls include confidence scoring to route uncertain results for human review, and audit logging for every AI suggestion and radiologist override to satisfy clinical governance. Deployment integrates with the hospital's RIS to dynamically prioritize worklists and with the EHR for reporting, creating a closed-loop system that measurably reduces manual segmentation time, standardizes follow-up recommendations, and provides the observability needed for continuous model monitoring in a regulated environment.

This workflow automates the repetitive, time-intensive process of manually reviewing screening CTs for pulmonary nodules. It directly addresses the operational bottleneck of radiologist capacity by deploying a multi-agent system that performs detection, feature extraction, and risk stratification before human review. The savings come from a 30-50% reduction in manual screening time per study, allowing radiologists to focus on high-risk cases and complex diagnostics, thereby increasing program throughput and improving early detection economics.

Implementation integrates directly with PACS/RIS via DICOM and HL7, using a LangGraph-based orchestrator to manage specialized agents for preprocessing, inference (using ensemble models), and scoring. Critical controls include confidence scoring to flag low-quality segmentations for human review, an immutable audit log of all AI inferences and overrides, and automated performance monitoring against a gold-standard dataset to detect model drift. The architecture is designed for phased rollout, starting with non-diagnostic prioritization before advancing to assisted reporting.

This workflow automates the repetitive screening bottleneck of manually reviewing hundreds of CT slices per study. The operational upside comes from a 30-50% reduction in radiologist contouring and measurement time, directly increasing screening program capacity. Implementation requires orchestrating specialized agents for DICOM preprocessing, nodule detection via 3D CNNs, and characterization models for size, density, and shape—all integrated with PACS for seamless study retrieval and result ingestion.

Phased delivery starts with the detection and characterization pipeline, validated against historical datasets. Phase two integrates the routing logic and alerting system with the hospital's communication platforms (e.g., secure chat, pager). The final phase implements the full clinical feedback loop, logging all physician overrides into a model performance monitoring system to enable continuous retraining. Governance is enforced through mandatory review gates for low-confidence results and all high-urgency findings before final sign-off.

The primary operational risk in automated nodule detection is false negatives and low-confidence classifications slipping through without review. Governance starts by architecting a multi-stage confidence scoring system, where every AI inference is assigned a risk score based on nodule size, morphology, and model certainty. Cases scoring below a configurable, audit-logged threshold are automatically routed to a human-in-the-loop review queue within the PACS or dedicated worklist software. This gate ensures radiologist oversight is applied precisely where the AI is uncertain, protecting patient safety while allowing high-confidence findings to proceed directly to reporting, unlocking the targeted 30-50% reduction in manual screening time.

Rollout must be phased, beginning with a silent pilot where AI runs in parallel with standard workflows, logging discrepancies without affecting clinical decisions. This phase validates performance benchmarks and refines confidence thresholds. Subsequent controlled go-live targets specific, high-volume screening protocols (e.g., Lung-RADS), integrating the workflow's API orchestration layer—built with frameworks like LangGraph for state management—with the PACS (e.g., Epic Radiant, Sectra). Continuous monitoring via a dedicated dashboard tracks key metrics: case escalation rate, average review time, and drift in AI performance against a gold-standard dataset, ensuring the system remains within defined clinical guardrails post-deployment.